Lumos Pharma Inc reports results for the quarter ended in December - Earnings Summary

Lumos Pharma

01/03/2023 22:12

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted
loss
of 99 cents​​ per share for the quarter ended in December. The
mean expectation of six analysts for the quarter was for a loss
of 93 cents per share.
    * Revenue rose 132.7% to $512.00 thousand from a year ago;
analysts expected $114.33 thousand. 
    * Lumos Pharma Inc's reported EPS for the quarter was a loss
of 99
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lumos Pharma Inc shares had fallen by 4.7% this quarter.
    * The company reported a quarterly loss of $8.25 million.
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $21.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 10:12 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.93          -0.99          Missed
 Sep. 30 2022      -1.01          -0.86          Beat
 Jun. 30 2022      -0.99          -0.94          Beat
 Mar. 31 2022      -0.89          -0.92          Missed